What is the current Price Target for the Alx Oncology Holdings Inc stock?

The average Alx Oncology Holdings Inc target price is $4.08. This is 131.82% higher than the current stock price. The highest price target is 257.95%, the lowest is 129.55%. 7 Analysts have issued a price target Alx Oncology Holdings Inc 2027 .

How high will the Alx Oncology Holdings Inc stock rise?

No reliable answer can be given as to how high the Alx Oncology Holdings Inc stock will rise. The performance of stocks, including the Alx Oncology Holdings Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Alx Oncology Holdings Inc stock today?

The performance of Alx Oncology Holdings Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Alx Oncology Holdings Inc stock fall?

The decline in Alx Oncology Holdings Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Alx Oncology Holdings Inc Forecast, price target & analysts

$1.75

0.85%

Nasdaq, Sep 17, 12:21 pm EDT. Market open.

ISIN

US00166B1052

Symbol

ALXO

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Alx Oncology Holdings Inc Target price 2026 - Analyst rating & recommendation

Alx Oncology Holdings Inc Classifications & Recommendation

Buy

85%

Hold

15%

Alx Oncology Holdings Inc Price Target

Target Price	$4.08
Price	$1.76
Potential	131.82% register free of charge
Number of Estimates	7

	7 Analysts have issued a price target Alx Oncology Holdings Inc 2027 . The average Alx Oncology Holdings Inc target price is $4.08. This is 131.82% register free of charge higher than the current stock price. The highest price target is $6.30 257.95% register free of charge , the lowest is $4.04 129.55% register free of charge .
	A rating was issued by 13 analysts: 11 Analysts recommend Alx Oncology Holdings Inc to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Alx Oncology Holdings Inc stock has an average upside potential 2027 of 131.82% register free of charge . Most analysts recommend the Alx Oncology Holdings Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '25	2026 Estimates
P/E		negative

8 Analysts have issued a Alx Oncology Holdings Inc forecast for earnings per share. The average Alx Oncology Holdings Inc EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2027	$-0.59 0.00% unlock
2028	$-0.57 3.39% unlock
2029	$-0.70 22.81% unlock
2030	$-0.58 17.14% unlock

Current	-2.98	513.55%
2026	-2.96 0.77% unlock
2027	-2.98 0.68% unlock
2028	-3.11 4.36% unlock

Alx Oncology Holdings Inc...

Current Alx Oncology Holdings Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Wells Fargo	Locked ➜ Locked	Locked	Mar 19 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 10 2026
Piper Sandler	Locked ➜ Locked	Locked	Feb 05 2026
UBS	Locked ➜ Locked	Locked	May 21 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	May 09 2025
Stifel	Locked ➜ Locked	Locked	Mar 07 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 07 2025

Analyst Rating	Date
Locked Wells Fargo: Locked ➜ Locked	Mar 19 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 10 2026
Locked Piper Sandler: Locked ➜ Locked	Feb 05 2026
Locked UBS: Locked ➜ Locked	May 21 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	May 09 2025
Locked Stifel: Locked ➜ Locked	Mar 07 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 07 2025

Discover more stocks with a high price target

NIO ADR 104.57%

Alibaba Group Holding Ltd 75.49%

Infineon 69.69%

Rheinmetall 60.60%

Tencent Holdings Ltd. 60.42%

TUI 52.29%

Siemens Energy 47.46%

Adyen 47.42%

Adidas 46.48%

Uber Technologies 45.16%

NVIDIA 43.06%

BYD 41.55%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now